University Of Dundee investment portfolio

Glen Clova Scientific develops and manufactures virus‑like particle therapeutic vaccines that enable patients to generate their own antibodies, offering a lower‑cost alternative to monoclonal‑antibody biologics for chronic inflammatory, autoimmune and other chronic diseases, and targeting patients who lack access to conventional biologic therapies.

Hawkhill Therapeutics develops a first‑in‑class oral therapy for obesity that selectively reduces fat mass while preserving muscle, aiming to improve metabolic health for people with excess weight.